ArticleDiabetes, obesity & metabolism2018

More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L.

Juan Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.